SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-23-006278
Filing Date
2023-03-13
Accepted
2023-03-13 07:57:22
Documents
1
Period of Report
2023-03-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4146
  Complete submission text file 0001437749-23-006278.txt   5711
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KEMPHARM, INC. 2500 CROSSPARK RD, STE E-126 CORALVILLE IA 52241
Business Address
Sangiovanni Timothy J. (Reporting) CIK: 0001698328 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 23725746